Olema Pharmaceuticals
OLMA
#5852
Rank
$1.12 B
Marketcap
$12.90
Share price
-5.08%
Change (1 day)
168.75%
Change (1 year)

Revenue for Olema Pharmaceuticals (OLMA)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Olema Pharmaceuticals from 2020 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA